The Journal of Pediatrics
Volume 155, Issue 4 , Pages 535-541.e1 , October 2009

Persistence of the Metabolic Syndrome Over 3 Annual Visits in Overweight Hispanic Children: Association with Progressive Risk for Type 2 Diabetes

  • Emily E. Ventura, PhD

      Affiliations

    • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
  • ,
  • Christianne J. Lane, MS

      Affiliations

    • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
  • ,
  • Marc J. Weigensberg, MD

      Affiliations

    • Department of Pediatrics, LAC + USC Medical Center, Los Angeles, CA
  • ,
  • Claudia M. Toledo-Corral, MS

      Affiliations

    • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
  • ,
  • Jaimie N. Davis, PhD

      Affiliations

    • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
  • ,
  • Michael I. Goran, PhD

      Affiliations

    • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
    • Corresponding Author InformationReprint requests: Michael I. Goran, 2250 Alcazar Street, CSC 212, Los Angeles, CA 90089-2211.

Received 6 December 2008 ,Revised 10 March 2009 ,Accepted 3 April 2009.

References 

  1. Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among US adolescents: a population-based study. Diabetes Care. 2006;29:2427–2432
  2. Cruz ML, Bergman RN, Goran MI. Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care. 2002;25:1631–1636
  3. Goran MI, Bergman RN, Gower BA. Influence of total versus visceral fat on insulin action and secretion in African-American and white children. Obes Res. 2001;9:423–431
  4. Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab. 2003;88:1417–1427
  5. Goran MI, Bergman RN, Cruz ML, Watanabe R. Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care. 2002;25:2184–2190
  6. Grundy SM. A constellation of complications: the metabolic syndrome. Clin Cornerstone. 2005;7:36–45
  7. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821–827
  8. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004;89:108–113
  9. National Center for Health Statistics. CDC Growth Charts: United States. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2000;
  10. American Diabetes Association. Clinical practice recommendations, 2002. Diabetes Care. 2002;25(Suppl 1):S1–S147
  11. Goran MI, Bergman RN, Avila Q, Watkins M, Ball GD, Shaibi GQ, et al. Impaired glucose tolerance and reduced beta-cell function in overweight Hispanic children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab. 2004;89:207–212
  12. Weigensberg MJ, Ball GD, Shaibi GQ, Cruz ML, Goran MI. Decreased beta-cell function in overweight Hispanic children with impaired fasting glucose. Diabetes Care. 2005;28:2519–2524
  13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics. 2004;114:555–576
  14. Tanner JM. Growth and maturation during adolescence. Nutr Rev. 1981;39:43–55
  15. Shaibi GQ, Goran MI. Examining metabolic syndrome definitions in overweight Hispanic youth: a focus on insulin resistance. J Pediatr. 2008;152:171–176
  16. Jones KL. The dilemma of the metabolic syndrome in children and adolescents: disease or distraction?. Pediatr Diabetes. 2006;7:311–321
  17. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  18. Fernandez JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004;145:439–444
  19. Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med. 1998;27:879–890
  20. Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation. 2007;115:2316–2322
  21. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–2374
  22. Ventura AK, Loken E, Birch LL. Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls. Pediatrics. 2006;118:2434–2442
  23. Franks PW, Hanson RL, Knowler WC, Moffett C, Enos G, Infante AM, et al. Childhood predictors of young-onset type 2 diabetes. Diabetes. 2007;56:2964–2972
  24. Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr. 2008;152:201–206
  25. Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care. 2001;24:89–94
  26. Haffner SM, Miettinen H, S.P. G, M.P. S. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995;44:1386–91.
  27. Buchanan TA. (How) can we prevent type 2 diabetes?. Diabetes. 2007;56:1502–1507
  28. Goran MI, Coronges K, Bergman RN, Cruz ML, Gower BA. Influence of family history of type 2 diabetes on insulin sensitivity in prepubertal children. J Clin Endocrinol Metab. 2003;88:192–195
  29. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23:381–389

 Supported by grants from the National Institutes of Health (R01 DK 59211), the General Clinical Research Center's National Center for Research Resources (MO1 RR 00043), and the National Cancer Institute's Center for Transdisciplinary Research on Energetics and Cancer (U54 CA 116848).

 The authors declare no conflicts of interest.

PII: S0022-3476(09)00363-1

doi: 10.1016/j.jpeds.2009.04.008

The Journal of Pediatrics
Volume 155, Issue 4 , Pages 535-541.e1 , October 2009